Agios Pharmaceuticals
AGIO
#5180
Rank
HK$13.11 B
Marketcap
HK$220.50
Share price
-2.26%
Change (1 day)
-4.81%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -HK$3.72 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are HK$66.04 Million. In 2025 the company made an earning of -HK$3.7 Billion a decrease over its 2024 earnings that were of -HK$3.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$3.72 Billion0.42%
2025 -HK$3.7 Billion10.9%
2024 -HK$3.34 Billion8.75%
2023 -HK$3.07 Billion0.63%
2022 -HK$3.05 Billion2.81%
2021 -HK$2.97 Billion10.58%
2020 -HK$2.69 Billion-18.41%
2019 -HK$3.29 Billion15.72%
2018 -HK$2.85 Billion12.99%
2017 -HK$2.52 Billion59.61%
2016 -HK$1.58 Billion69.32%
2015 -HK$0.94 Billion119.28%
2014 -HK$0.43 Billion39.22%
2013 -HK$0.31 Billion69.1%
2012 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.98 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.89 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.44 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-HK$1.09 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$7.86 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA